Articles

The Oncology Nurse–APN/PA conducted an interview with Jennifer Temel, MD. The written interview is based on a presentation at the 2015 Annual Meeting of the American Society of Clinical Oncology, Phase III Trials for Anamorelin in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia (ROMANA 1 and 2). Read More ›

The State of Antibody-Drug Conjugates in 2015

By Phoebe Starr

Drug Therapies

TON September 2015 Vol 8 No 5

Antibody-drug conjugates (ADCs) offer a unique approach for the treatment of solid tumors and hematologic cancers. The idea is that a potent cytotoxic agent is linked to an antibody specifically targeted to tumor cells, and once the antibody binds to the tumor cell, the cytotoxic agent is unleashed inside the cells to attack the cancer. Read More ›

Managing Cytokine Release Syndrome

By Alice Goodman

Best Practices

TON September 2015 Vol 8 No 5

Nurses may not recognize the early signs of cytokine release syndrome (CRS) if they are not experienced with administering immune-based therapies. Read More ›

Management Options with Obinutuzumab

By Alice Goodman

Best Practices

TON September 2015 Vol 8 No 5

Treatment for chronic lymphocytic leukemia (CLL) has come a long way with the availability of new drugs that improve outcomes. As new treatments become available, there is a corresponding learning curve. Read More ›

Antiemesis Prophylaxis Remains Inadequate

By Meg Barbor, MPH

Supportive Care

TON September 2015 Vol 8 No 5

Approximately 40% of patients treated with anthracyclines are still not receiving National Comprehensive Cancer Network (NCCN) guideline–adherent prophylaxis for chemotherapy-induced vomiting. Read More ›

Beth Faiman, PhD, APRN-BC, AOCN, Nominated for LLS Woman of the Year

By Beth Faiman, PhD, APRN-BC, AOCN

Original Research, Audiocast

Audiocasts

In a recent interview with The Oncology Nurse-APN/PA (TON), Beth Faiman, PhD, APRN-BC, AOCN, Nurse Practitioner, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, and Editor-in-Chief of TON discussed her recent acceptance of a nomination for the Leukemia & Lymphoma Society (LLS) Woman of the Year award. Read More ›

From the Editor

TON July 2015 Vol 8 No 4

In this month’s issue of The Oncology Nurse-APN/PA (TON), we start our coverage of the news from the recent Oncology Nursing Society (ONS) 40th Annual Congress and the 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO). Read More ›

Rutgers Cancer Institute of New Jersey

Cancer Center Profile

TON July 2015 Vol 8 No 4

TON spoke with Carla Schaefer about the challenges and the rewards of working as a nurse manager at the Rutgers Cancer Institute of New Jersey, a leader in advanced comprehensive care and cancer research. Read More ›

AONN+ Granted Membership in the American College of Surgeons Commission on Cancer

AONN+ News

TON July 2015 Vol 8 No 4

“As a CoC member, we look forward to joining forces with some of the nation’s foremost oncology organizations to help write and implement policy that ensures patients have access to the highest standard of care available for their cancer,” said Lillie Shockney, AONN+ program director. Read More ›

Boosting Uptake of the HPV Vaccine

By Alice Goodman

Best Practices

TON July 2015 Vol 8 No 4

At the ONS 2015 meeting, experts shared their clinical advice for addressing the barriers to HPV vaccination uptake among boys, girls, and young men and women. Read More ›

Articles

View the Latest Issue of TON

Subscribe Today!

I'd like to receive:

Articles

Page 212 of 376

View the Latest Issue of TON

Subscribe Today!

I'd like to receive: